The dialogue around Canada’s opioid crisis is transforming, moving away from stigma and embracing a more compassionate approach centered on treatment. With overdose rates climbing alarmingly, policymakers and advocates are rallying for innovative solutions that emphasize harm reduction and robust mental health support.
A recent investigation by BBC reveals that an Indian pharmaceutical company is significantly contributing to West Africa’s escalating opioid crisis. The report highlights alarming practices, including the production and distribution of potent opioids, raising concerns about public health and regulatory oversight in the region.
